DOSSIER · 13F-HR · Q4 2025

Vantage Consulting Group Inc

$20M in tracked AUM across 3 positions as of Q4 2025.

VC
CIK 0001843547 · last filed Dec 31, 2025
Total AUM
$20M
as of Q4 2025
Holdings
3
+3 QoQ
positions
Whale Score
53
53
tracked
Activity
3
+3 new, −0 sold
changes this Q
AI Analysis · Q4 2025

Vantage Consulting Group Inc filed its latest 13F-HR for Q4 2025. 3 position changes this quarter — 3 new, 0 exited, 0 added, 0 trimmed.

Quarter at a glance — Q4 2025

3 material changes this filing.

NEW
BWBabcock & Wilcox Enterprises Inc.
+2.4M sh
+$15M
77.7%
NEW
H0036K147ADC Therapeutics SA
+683K sh
+$2M
12.2%
NEW
CBUSCibus, Inc.
+1.1M sh
+$2M
10.1%

Top 10 holdings

By portfolio weight as of Q4 2025. Source: SEC EDGAR 13F-HR filings.

#HoldingValueSharesWeight
01
BW
Babcock & Wilcox Enterprises Inc.
$15M2.4M77.7%
02
H0036K147
ADC Therapeutics SA
$2M683K12.2%
03
CBUS
Cibus, Inc.
$2M1.1M10.1%

Filing history

2025Q4Dec 31
$20M▲ 75.8%
3 positionsView →
2025Q3Sep 30
$11M▲ 95.6%
3 positionsLocked
2025Q2Jun 30
$6M▲ 14.1%
3 positionsLocked
2025Q1Mar 31
$5M▼ 52.1%
4 positionsLocked
2024Q4Dec 31
$10M▼ 8.1%
5 positionsLocked
2024Q3Sep 30
$11M▼ 91.5%
4 positionsLocked
2024Q2Jun 30
$135M▼ 14.4%
191 positionsLocked
2024Q1Mar 31
$157M▲ 5.7%
212 positionsLocked
2023Q4Dec 31
$149M▼ 0.2%
208 positionsLocked
2023Q3Sep 30
$149M▼ 14.2%
200 positionsLocked
2023Q2Jun 30
$174M▼ 1.3%
216 positionsLocked
2023Q1Mar 31
$176M▲ 4.0%
231 positionsLocked
Showing 12 of 21